BRIEF-Medicis and Impax Labs terminate legal dispute -
BRIEF-Medicis, Impax announce R&D development collaboration and settlement -
Medicis and IMPAX Announce R&D Collaboration and Settlement -
MRX: To Present At Credit Suisse Healthcare Conference @ 11:30 ET [delayed] -
Medicis to Present At Credit Suisse Healthcare Conference -
Medicis Pharmaceutical Provides Mixed Guidance -
BRIEF-Medicis reports Q3 results -
Medicis Reports Third Quarter 2008 Financial Results -
MRX: Q3 Earnings Call @ 17:15 ET Today [delayed] -
Medicis Announces Third Quarter 2008 Conference Call and Webcast -
The Pomerantz Firm Charges Medicis Pharmaceutical Corporation With Securities Fraud -- MRX -
CREDIT SUISSE CUTS MEDICIS PHARMACEUTICAL PRICE TARGET TO $16 FROM $18 -
Izard Nobel LLP Announces Class Action Lawsuit against Medicis Pharmaceuticals Corporation -
Medicis receives FDA approval of PMA supplement for wrinkle treatment drug -
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Medicis Pharmaceutical Corporation -